Abstract
Safety, efficacy, and pharmacokinetics of interferon alfa-2B plus ribavirin in children with chronic hepatitis C: Deirdre A Kelly Dr, Su K Bunn, Liver Unit, Birmingham Children's Hospital, Birmingham Uk; David Apelian, Andrew Baczkowski, Samir Gupta, Mark Laughlin, Marielle Cohard, Schering Plough Research Institute, Kenilworth, NJ
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
